NanoString Technologies Inc (NASDAQ:NSTG)
| 8.93 Delayed Data As of Mar 28 |  -0.08 / -0.89%Today’s Change | 4.37 Today|||52-Week Range 37.06 | +12.05% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $389.3M |
Company Description
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. It offers the GeoMx Digital Spatial Profiler, nCounter Analysis System product platforms, GeoMx Assays, nCounter Panels & Assays and CosMx Spatial Molecular. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June, 2003 and is headquartered in Seattle, WA.
Contact Information
NanoString Technologies, Inc. 530 Fairview Avenue North Seattle Washington 98109 |
Employees
Shareholders
| Other institutional | 59.61% |
| Mutual fund holders | 39.65% |
| Individual stakeholders | 15.48% |
Top Executives
| Robert Bradley Gray | President, Chief Executive Officer & Director |
| Mark A. Winham | Senior Vice President-Operations |
| Kenneth Thomas Bailey | Chief Financial Officer |
| Joseph M. Beechem | Chief Scientific Officer, SVP-R&D |
| David W. Ghesquiere | Senior VP-Corporate & Business Development |
